A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

NCT06486051 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Transformed Non-Hodgkin Lymphoma

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: WZTL-002 CAR T-cells

Sponsor

Malaghan Institute of Medical Research

Collaborators

[object Object]
[object Object]